Clinical practice. Acute vulvovaginitis.
Eckert LO.
N Engl J Med. 2006 Sep 21;355(12):1244-52. doi: 10.1056/NEJMcp053720.
Acute vulvovaginitis.
Shirley RL.
N Engl J Med. 2006 Dec 28;355(26):2791; author reply 2791. doi: 10.1056/NEJMc062854.
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
MacAlpine J, Lionakis MS.
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
Candidiasis (vulvovaginal).
Martin Lopez JE.
BMJ Clin Evid. 2015 Mar 16;2015:0815.
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W.
Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.
Probiotics.
Williams NT.
Am J Health Syst Pharm. 2010 Mar 15;67(6):449-58. doi: 10.2146/ajhp090168.
Urinary retention in adults: diagnosis and initial management.
Selius BA, Subedi R.
Am Fam Physician. 2008 Mar 1;77(5):643-50.
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations.
Day T, Sobel JD.
Clin Microbiol Rev. 2025 Jun 12;38(2):e0002025. doi: 10.1128/cmr.00020-25. Epub 2025 May 28.
Fanconi Anemia.
Mehta PA, Ebens CL.
2002 Feb 14 [updated 2026 Jan 15]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
Candidiasis (vulvovaginal).
Spence D.
BMJ Clin Evid. 2010 Jan 5;2010:0815.
